Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

4.6K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
4.6K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

1.7K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.7K
Drug Discovery: Overview01:26

Drug Discovery: Overview

12.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.9K
Drug Regulation01:25

Drug Regulation

3.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.3K
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

456
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
456
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

8.2K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
8.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SmartChart Suite: a Fast Healthcare Interoperability Resources-based framework for longitudinal syphilis surveillance using structured and unstructured data.

JAMIA open·2024
Same author

A High-Fidelity Combined ATC-Rxnorm Drug Hierarchy for Large-Scale Observational Research.

Studies in health technology and informatics·2024
Same author

Real-World Patient Characteristics, Utilization Patterns, and Outcomes of US Patients with HR+, HER2- Metastatic Breast Cancer Treated with Abemaciclib.

Drugs - real world outcomes·2022
Same author

Comparative Effectiveness of Dexamethasone in Hospitalized COVID-19 Patients in the United States.

Advances in therapy·2022
Same author

A review of stakeholder recommendations for defining fit-for-purpose real-world evidence algorithms.

Journal of comparative effectiveness research·2022
Same author

Inpatient Hospital Costs for COVID-19 Patients in the United States.

Advances in therapy·2021

Related Experiment Video

Updated: Mar 24, 2026

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
06:40

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management

Published on: June 29, 2019

7.1K

An Interactive User Interface for Drug Labeling to Improve Readability and Decision-Making.

Hamed Abedtash1, Jon D Duke2

  • 1School of Informatics and Computing, Indiana University, Indianapolis, IN.

AMIA ... Annual Symposium Proceedings. AMIA Symposium
|March 10, 2016
PubMed
Summary

This study introduces myDrugLabel, a web application designed to simplify complex FDA drug labels. It personalizes drug information, improving usability for healthcare providers by reducing cognitive load.

More Related Videos

A Web Tool for Generating High Quality Machine-readable Biological Pathways
08:01

A Web Tool for Generating High Quality Machine-readable Biological Pathways

Published on: February 8, 2017

18.7K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.6K

Related Experiment Videos

Last Updated: Mar 24, 2026

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
06:40

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management

Published on: June 29, 2019

7.1K
A Web Tool for Generating High Quality Machine-readable Biological Pathways
08:01

A Web Tool for Generating High Quality Machine-readable Biological Pathways

Published on: February 8, 2017

18.7K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.6K

Area of Science:

  • Pharmacology
  • Health Informatics
  • Medical Usability

Background:

  • FDA-approved prescribing information is critical but often overly complex and difficult to read.
  • High cognitive load from current drug labels can impact healthcare provider decision-making.
  • Existing drug labels may not effectively convey patient-specific safety information.

Purpose of the Study:

  • To improve the usability of FDA drug labels for healthcare professionals.
  • To enhance the 'signal-to-noise ratio' of drug information.
  • To provide patient-specific, meaningful safety data by integrating comorbidities and concomitant medications.

Main Methods:

  • Developed a web application, myDrugLabel, using Structured Product Label documents as a foundation.
  • Implemented label personalization based on patient-specific factors.
  • Enhanced label readability and integrated diverse evidence sources.
  • Incorporated data from PubMed, FDA adverse event reporting system (FAERS), and social media signals.

Main Results:

  • Designed and created the myDrugLabel web application.
  • Established a process for personalizing drug label content.
  • Successfully integrated multiple evidence sources into the drug label format.
  • Improved the delivery of relevant safety information to care providers.

Conclusions:

  • The myDrugLabel application offers a novel approach to enhance drug label usability.
  • Personalized and improved drug labels can reduce cognitive load for healthcare professionals.
  • Integrating diverse data sources into drug labels provides more meaningful and actionable safety information.